Richmond, Prof Peter_V2

Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician, Perth Children’s Hospital. Head, Department of Immunology, Child & Adolescent Health Service WA. Director, Vaccine Trials Group, Wesfarmers Centre of Vaccines & Infectious Diseases, The Kids Research Institute Australia.
Professor Peter Richmond is a Consultant Paediatric Immunologist and Paediatrician at Perth Children’s Hospital and is Head of the Immunology Department at the Child and Adolescent Health Service in WA. He also heads the Vaccine Trials Group within the Wesfarmers Centre of Vaccines and Infectious Diseases at The Kids Research Institute Australia, and is Head of the Discipline of Paediatrics at the University of Western Australia Medical School. His major research interests are in the prevention of meningitis, pneumonia, respiratory infections and otitis media. He has authored over 300 scientific publications in these areas and has worked in vaccine research for over 25 years.

More from this expert

Videos iconVideos

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Conversation strategies to educate patients so that they can make a realistic assessment of the cost benefit equation.

Podcasts iconPodcasts

In this Product Explainer, Paediatrician and Paediatric Immunologist A/Prof Peter Richmond explains which patients are most at risk for meningococcal B, the risk reduction benefits of meningococcal B vaccination and why it is important to have conversations with parents in which the risk/benefits of vaccination are clearly explained (5 mins).

Videos iconVideos

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Videos iconVideos

The incidence of meningitis in adolescents and young people

Podcasts iconPodcasts

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

Podcasts iconPodcasts

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

Podcasts iconPodcasts

In this Product Explainer, Consultant Paediatric Immunologist and Paediatrician Prof Peter Richmond provides an update on the 20vPnC pneumococcal conjugate vaccine including availability and eligibility (4 mins).

Videos iconVideos

Last chance - $155 special ends midnight Sunday!

This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.

Upcoming Healthed Webcast

POTS – What You Need to Know

Tuesday 17th February, 7pm - 9pm AEDT

Speaker

Prof Dennis Lau

Cardiac Electrophysiologist; The Royal Adelaide Hospital; Clinical Professor, The University of Adelaide

Hear the latest evidence-based management options for POTS - a common, yet poorly recognised and misunderstood autonomic dysfunction condition in our community. Join Prof Dennis Lau for an update on POTS, who is at risk, presenting symptoms and how it can be diagnosed in the primary care setting.